Low levels of specific T cell activation marker CD27 accompanied by elevated levels of markers for non-specific immune activation in the cerebrospinal fluid of patients with AIDS dementia complex

Bahraoui, 1991, Evidence for neurotoxic activity of Tat from human immunodeficiency virus (HIV-1) Brew, 1989, Cerebrospinal fluid β-2-microglobulin in patients infected with human immunodeficiency virus type 1, Neurology, 39, 830, 10.1212/WNL.39.6.830 Brew, 1990, CSF neopterin in HIV-1 infection, Ann. Neurol., 28, 556, 10.1002/ana.410280413 Centers for Disease Control, 1987, Revision of the CDC surveillance case definition for acquired immunodeficiency syndrome, MMWR, 36, 1S Dembic, 1990, Two human TNF receptors have similar extracellular, but distinct intracellular, domain sequences, Cytokine, 2, 231, 10.1016/1043-4666(90)90022-L Epstein, 1987, Expression of human immunodeficiency virus in cerebrospinal fluid of children with progressive encephalopathy, Ann. Neurol., 21, 397, 10.1002/ana.410210413 Everall, 1991, Neuronal loss in the frontal cortex in HIV infection, Lancet, 337, 1119, 10.1016/0140-6736(91)92786-2 Fauci, 1991, Immunopathogenic mechanisms in human immunodeficiency viru (HIV) infection, Ann. Intern. Med., 114, 678, 10.7326/0003-4819-114-8-678 Gallo, 1989, Human immunodeficiency virus type 1 (HIV-1) infection of the central nervous system: an evaluation of cytokines in cerebrospinal fluid, J. Neuroimmunol., 23, 109, 10.1016/0165-5728(89)90029-5 Giulian, 1990, Secretion of neurotoxins by mononuclear phagocytes infected with HIV-1, Science, 250, 1593, 10.1126/science.2148832 Godfried, 1993, Soluble receptors for tumour necrosis factor: a putative marker of disease progression in HIV infection, AIDS, 7, 33, 10.1097/00002030-199301000-00005 Goudsmit, 1986, Intrathecal synthesis of antibodies to HTLV-III in patients without AIDS or AIDS related complex, Br. Med. J., 292, 1231, 10.1136/bmj.292.6530.1231 Goudsmit, 1986, Expression of human immunodeficiency virus antigen in serum and cerebrospinal fluid during acute and chronic infection, Lancet, ii, 177, 10.1016/S0140-6736(86)92485-2 Goudsmit, 1987, Intra-blood-brain barrier synthesis of human immunodeficiency virus antigen and antibody in humans and chimpanzees, 84, 3876 Greenberg, 1988, Elevated levels of soluble interleukin-2 receptors in multiple sclerosis, N. Engl. J. Med., 319, 1019, 10.1056/NEJM198810133191518 Grimaldi, 1991, Elevated alpha-tumor necrosis factor levels in spinal fluid from HIV-1-infected patients with central nervous system involvement, Ann Neurol., 29, 21, 10.1002/ana.410290106 Hintzen, 1991, Elevated levels of a soluble form of the T cell activation antigen CD27 in cerebrospinal fluid of multiple sclerosis patients, J. Neuroimmunol., 35, 211, 10.1016/0165-5728(91)90175-7 Hintzen, 1991, A soluble form of the human T cell differentiation antigen CD27 is released after triggering of the TCR/CD3 complex, J. Immunol., 147, 29, 10.4049/jimmunol.147.1.29 Ho, 1985, Isolation of HTLV-III from cerebrospinal fluid and neural tissue of patients with neurologic syndromes related to the acquired immune deficiency syndrome, N. Engl. J. Med., 313, 1493, 10.1056/NEJM198512123132401 Loenen, 1991, The T cell activation molecule CD27 is a member of the NGF-R gene family, Vol. H52, 131 Loenen, 1992, Genomic organization and chromososmal localization of the human CD27 gene, J. Immunol., 149, 3937, 10.4049/jimmunol.149.12.3937 Loetscher, 1990, Molecular cloning and expression of the human 55kd tumor necrosis factor receptor, Cell, 61, 351, 10.1016/0092-8674(90)90815-V Marshall, 1988, Spectrum of CSF findings in various stages of HIV infection, Arch. Neurol., 45, 954, 10.1001/archneur.1988.00520330032007 Mastroianni, 1992, Tumour necrosis factor (TNF-α) and neurological disorders in HIV infection, J. Neurol. Neurosurg. Psych., 55, 219, 10.1136/jnnp.55.3.219 Matsuyama, 1991, Cytokines and HIV infection: is AIDS a tumor necrosis factor disease?, AIDS, 5, 1405, 10.1097/00002030-199112000-00001 Perrella, 1992, Cerebrospinal fluid cytokines in AIDS dementia complex, J. Neurol., 239, 387, 10.1007/BF00812156 Portegies, 1989, Human immunodeficiency virus type 1 antigen in cerebrospinal fluid. Correlation with clinical neurologic status, Arch. Neurol., 46, 261, 10.1001/archneur.1989.00520390027010 Portegies, 1993, Presentation and course of AIDS dementia complex: Ten years of follow-up in Amsterdam, The Netherlands, AIDS, 7, 669, 10.1097/00002030-199305000-00010 Price, 1988, The brain in AIDS: central nervous system HIV-1 infection and the AIDS dementia complex, Science, 239, 586, 10.1126/science.3277272 Resnick, 1985, Intra-blood-brain barrier synthesis of HTLV-III specific IgG in patients with neurologic symptoms associated with AIDS or AIDS-related complex, N. Engl. J. Med., 313, 1498, 10.1056/NEJM198512123132402 Robb, 1987, Structure-function relationships for the IL 2-receptor system. IV. Analysis of the sequence and ligand-binding properties of soluble Tac protein, J. Immunol., 139, 855, 10.4049/jimmunol.139.3.855 Rubin, 1990, The soluble interleukin-2 receptor: biology, function and clinical application, Ann. Intern. Med., 113, 619, 10.7326/0003-4819-113-8-619 Van Lier, 1987, Tissue distribution and biochemical and functional properties of Tp55 (CD27), a novel T cell differentiation antigen, J. Immunol., 139, 1589, 10.4049/jimmunol.139.5.1589